Paul Stupple

Paul Stupple works at Monash University in Melbourne, Australia as Director of Medicinal Chemistry for Cancer Therapeutics CRC (CTx). His research focus is on small molecule drug discovery for oncology, with a focus on epigenetics and immuno-oncology. Prior to joining CTx in 2012, Paul worked at Pfizer Laboratories in Sandwich, UK, where he led medicinal chemistry teams that delivered numerous clinical candidates of which three have so far reached Phase II clinical trials.